Article
Dual therapy with peg-interferon and ribavirin in thalassemia major patients with chronic HCV infection: Is there still an indication?
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver - 1 Jun 2016
Di Marco Vito, D'Ambrosio Roberta, Bronte Fabrizio, Saracco Giorgio, Lanza Alfonso Galeota, Forni Gianluca, Poggiali Erika, Calvaruso Vincenza
Abstract excerpt
BACKGROUND: Iron overload and hepatitis C virus (HCV) infection together can lead to chronic liver damage in thalassemia major (TM) patients. AIMS: We investigated viral, genetic, and disease factors influencing sustained virological response (SVR) after peg-interferon and ribavirin therapy in TM patients with HCV infection. METHODS: We analyzed 230 TM patients with HCV infection (mean age 36.0±6.3 years; 59.1%...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.